BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38798793)

  • 21. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness.
    Goldenberg NA; Sochet A; Albisetti M; Biss T; Bonduel M; Jaffray J; MacLaren G; Monagle P; O'Brien S; Raffini L; Revel-Vilk S; Sirachainan N; Williams S; Zia A; Male C;
    J Thromb Haemost; 2020 Nov; 18(11):3099-3105. PubMed ID: 33174388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.
    Chi G; Goldhaber SZ; Kittelson JM; Turpie AGG; Hernandez AF; Hull RD; Gold A; Curnutte JT; Cohen AT; Harrington RA; Gibson CM
    J Thromb Haemost; 2017 Oct; 15(10):1913-1922. PubMed ID: 28762617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
    Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge.
    Wang L; Sengupta N; Baser O
    Thromb J; 2011 Oct; 9(1):15. PubMed ID: 21995820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
    Dwyer JP; Javed A; Hair CS; Moore GT
    Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis.
    Valeriani E; Porfidia A; Ageno W; Spoto S; Pola R; Di Nisio M
    Intern Emerg Med; 2022 Sep; 17(6):1817-1825. PubMed ID: 35759185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematologists' awareness of venous thromboembolism in multiple myeloma: a national survey in China.
    Li Q; Zhang B; Cheng Q; Zhao F; Li J; Yan H; Xu A; Sun C; Hu Y
    Ann Med; 2023; 55(2):2263019. PubMed ID: 37983471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.
    Davidson BL; Verheijen S; Lensing AW; Gebel M; Brighton TA; Lyons RM; Rehm J; Prins MH
    JAMA Intern Med; 2014 Jun; 174(6):947-53. PubMed ID: 24733305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended venous thromboprophylaxis in patients hospitalized for acute ischemic stroke: A systematic review and meta-analysis.
    Valeriani E; Potere N; Candeloro M; Spoto S; Porreca E; Rutjes AW; Di Nisio M
    Eur J Intern Med; 2022 Jan; 95():80-86. PubMed ID: 34649783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.
    Zwicker JI; Rojan A; Campigotto F; Rehman N; Funches R; Connolly G; Webster J; Aggarwal A; Mobarek D; Faselis C; Neuberg D; Rickles FR; Wun T; Streiff MB; Khorana AA
    J Clin Oncol; 2014 Jun; 32(17):1792-6. PubMed ID: 24799475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous Thromboembolism in Total Hip and Total Knee Arthroplasty.
    Simon SJ; Patell R; Zwicker JI; Kazi DS; Hollenbeck BL
    JAMA Netw Open; 2023 Dec; 6(12):e2345883. PubMed ID: 38039005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
    Tzoran I; Brenner B; Sakharov G; Trujillo-Santos J; Lorenzo A; Madridano O; López-Sáez JB; Monreal M;
    Eur J Intern Med; 2014 Nov; 25(9):821-5. PubMed ID: 25287697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
    McLaughlin HD; Greco P; Straubhar AM; Rolston A; McCool K; Brackmann M; Siedel JH; McLean K; Reynolds RK; Uppal S
    Gynecol Oncol; 2023 Nov; 178():89-95. PubMed ID: 37832182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic Venous Thromboembolism and Major Bleeding After Renal Transplantation: Should We Use Pharmacologic Thromboprophylaxis?
    Musso D; Robaina GI; Figueroa Córdoba AV; Martini GD; Albertini RA; Chiurchiu C; Tabares AH
    Transplant Proc; 2016 Oct; 48(8):2773-2778. PubMed ID: 27788816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
    Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K
    JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study.
    Shatzel J; Dulai PS; Harbin D; Cheung H; Reid TN; Kim J; James SL; Khine H; Batman S; Whyman J; Dickson RC; Ornstein DL
    J Thromb Haemost; 2015 Jul; 13(7):1245-53. PubMed ID: 25955079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction and Prevention of Cancer-Associated Thromboembolism.
    Khorana AA; DeSancho MT; Liebman H; Rosovsky R; Connors JM; Zwicker J
    Oncologist; 2021 Jan; 26(1):e2-e7. PubMed ID: 33274815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.
    Lim W; Meade M; Lauzier F; Zarychanski R; Mehta S; Lamontagne F; Dodek P; McIntyre L; Hall R; Heels-Ansdell D; Fowler R; Pai M; Guyatt G; Crowther MA; Warkentin TE; Devereaux PJ; Walter SD; Muscedere J; Herridge M; Turgeon AF; Geerts W; Finfer S; Jacka M; Berwanger O; Ostermann M; Qushmaq I; Friedrich JO; Cook DJ;
    Crit Care Med; 2015 Feb; 43(2):401-10. PubMed ID: 25474533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism prophylaxis in patients hospitalized in medical wards: A real life experience.
    Mahlab-Guri K; Otman MS; Replianski N; Rosenberg-Bezalel S; Rabinovich I; Sthoeger Z
    Medicine (Baltimore); 2020 Feb; 99(7):e19127. PubMed ID: 32049830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.